|
US20110097352A9
(en)
*
|
1992-01-29 |
2011-04-28 |
Pharmexa Inc. |
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
|
|
US7611713B2
(en)
*
|
1993-03-05 |
2009-11-03 |
Pharmexa Inc. |
Inducing cellular immune responses to hepatitis B virus using peptide compositions
|
|
US9266930B1
(en)
|
1993-03-05 |
2016-02-23 |
Epimmune Inc. |
Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions
|
|
US6265215B1
(en)
*
|
1996-09-13 |
2001-07-24 |
Ludwig Institute For Cancer Research |
Isolated peptides which complex with HLA-Cw16 and uses thereof
|
|
WO1999003972A1
(en)
*
|
1997-07-15 |
1999-01-28 |
Takara Shuzo Co., Ltd. |
Cytotoxic t lymphocytes
|
|
US6183746B1
(en)
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
|
CA2323632A1
(en)
*
|
1998-03-13 |
1999-09-16 |
Epimmune Inc. |
Hla-binding peptides and their uses
|
|
US6534482B1
(en)
*
|
1998-05-13 |
2003-03-18 |
Epimmune, Inc. |
Expression vectors for stimulating an immune response and methods of using the same
|
|
US6838445B1
(en)
*
|
1998-07-10 |
2005-01-04 |
Kyogo Itoh |
Tumor antigen peptide originating in SART-1
|
|
US20070020327A1
(en)
*
|
1998-11-10 |
2007-01-25 |
John Fikes |
Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
|
|
US6395714B1
(en)
*
|
1999-02-24 |
2002-05-28 |
Aventis Pasteur Limited |
Expressing gp140 fragment of primary HIV-1 isolate
|
|
GB9905911D0
(en)
*
|
1999-03-15 |
1999-05-05 |
Photocure As |
Method
|
|
WO2001021189A1
(en)
*
|
1999-07-19 |
2001-03-29 |
Epimmune Inc. |
Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
|
|
WO2001024810A1
(en)
*
|
1999-10-05 |
2001-04-12 |
Epimmune Inc. |
Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
|
|
EP1230268B1
(en)
*
|
1999-11-18 |
2009-10-14 |
Pharmexa Inc. |
Heteroclitic analogs of class i epitopes
|
|
US7026443B1
(en)
|
1999-12-10 |
2006-04-11 |
Epimmune Inc. |
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
|
|
CA2393662A1
(en)
*
|
1999-12-10 |
2001-06-14 |
Epimmune Inc. |
Inducing cellular immune responses to p53 using peptide and nucleic acid compositions
|
|
EP1235848A4
(en)
*
|
1999-12-10 |
2005-02-09 |
Epimmune Inc |
INDUCING CELLULAR IMMUNE RESPONSES TO CARCINOEMBRYONIC ANTIGEN USING PEPTIDE AND NUCLEIC ACID-CONTAINING COMPOSITIONS
|
|
US20070098776A1
(en)
*
|
1999-12-13 |
2007-05-03 |
Fikes John D |
HLA class I A2 tumor associated antigen peptides and vaccine compositions
|
|
JP2003521245A
(ja)
*
|
1999-12-21 |
2003-07-15 |
エピミューン， インコーポレイテッド |
ペプチドおよび核酸組成物を使用する、前立腺癌抗原に対する細胞性免疫応答の誘導
|
|
US20040248113A1
(en)
*
|
1999-12-28 |
2004-12-09 |
Alessandro Sette |
Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby
|
|
US7462354B2
(en)
*
|
1999-12-28 |
2008-12-09 |
Pharmexa Inc. |
Method and system for optimizing minigenes and peptides encoded thereby
|
|
US6399067B1
(en)
*
|
2000-04-28 |
2002-06-04 |
Thymon L.L.C. |
Methods and compositions for impairing multiplication of HIV-1
|
|
CA2421448A1
(en)
*
|
2000-09-01 |
2002-03-14 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
US20040121946A9
(en)
*
|
2000-12-11 |
2004-06-24 |
John Fikes |
Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
|
|
AU2002305138A1
(en)
|
2001-04-09 |
2002-10-21 |
Mayo Foundation For Medical Education And Research |
Methods and materials for cancer treatment
|
|
US20070054262A1
(en)
*
|
2003-03-28 |
2007-03-08 |
Baker Denise M |
Methods of identifying optimal variants of peptide epitopes
|
|
AU2005222776A1
(en)
*
|
2003-12-31 |
2005-09-29 |
Genimmune N.V. |
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
|
|
CA2566506A1
(en)
*
|
2004-06-01 |
2005-12-15 |
Innogenetics N.V. |
Peptides for inducing a ctl and/or htl response to hepatitis c virus
|
|
EP1842911A4
(en)
*
|
2005-01-25 |
2008-12-10 |
Nec Corp |
HLA BINDING PEPTIDES, FOR THOSE CODING DNA FRAGMENTS AND RECOMBINANT VECTORS
|
|
JP2008535783A
(ja)
|
2005-02-15 |
2008-09-04 |
サイモン・エル・エル・シー |
Ｈｉｖ−１の増殖を弱めるための方法および組成物
|
|
CN103864893B
(zh)
*
|
2007-07-27 |
2017-01-04 |
伊玛提克斯生物技术有限公司 |
免疫疗法的免疫抗原表位
|
|
EP2391635B1
(en)
|
2009-01-28 |
2017-04-26 |
Epimmune Inc. |
Pan-dr binding polypeptides and uses thereof
|
|
JP2010001303A
(ja)
*
|
2009-08-17 |
2010-01-07 |
Pharmexa Inc |
Ｈｌａ結合ペプチド及びその使用
|
|
EP2745845A1
(en)
|
2012-12-19 |
2014-06-25 |
Centre Hospitalier Universitaire de Bordeaux |
A method for preventing or treating an HIV infection
|
|
CN120712104A
(zh)
*
|
2022-10-14 |
2025-09-26 |
广东天科雅生物医药科技有限公司 |
针对神经胶质瘤的肽疫苗及其用途
|